Fortress Biotech, Inc. (NASDAQ:FBIOP) Sees Large Decrease in Short Interest

Fortress Biotech, Inc. (NASDAQ:FBIOP) saw a significant decrease in short interest in March. As of March 31st, there was short interest totalling 4,800 shares, a decrease of 14.3% from the March 15th total of 5,600 shares. Based on an average daily trading volume, of 11,900 shares, the days-to-cover ratio is currently 0.4 days.

Fortress Biotech Stock Down 13.1 %

FBIOP stock opened at $15.22 on Tuesday. Fortress Biotech has a one year low of $6.40 and a one year high of $18.91. The firm has a 50-day moving average of $15.88 and a two-hundred day moving average of $13.38.

Fortress Biotech Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Tuesday, April 30th. Stockholders of record on Monday, April 15th will be issued a $0.1953 dividend. The ex-dividend date of this dividend is Friday, April 12th. This represents a $2.34 dividend on an annualized basis and a dividend yield of 15.40%.

Fortress Biotech Company Profile

Fortress Biotech, Inc, a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino an oral minocycline drug for the treatment of moderate to severe acne; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Exelderm cream for antifungal intended for topical use; Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Amzeeq; Zilxi; and Accutane capsules for severe recalcitrant nodular acne.